BioSpace News Archive

Policy

FDA Action Alert: Merck, Ligand and Albireo Pharma

There are two PDUFA dates on the U.S. Food and Drug Administration’s calendar for this week. Here’s a look.

July 16, 2021
·
3 min read
·
Mark Terry
Revealing Employee Burnout Signs

Addressing employee burnout signs at an early stage will help build a healthy relationship. It can also help improve the performance. Let’s look at some other benefits.

July 16, 2021
·
5 min read
·
Lorenzo Soliman
Ultrasound Probe Market: Increase in the number of ultrasound procedures to drive the market

Ultrasound probes are designed to produce high frequency sound waves within the body tissues that in turn produce echoes.

July 16, 2021
·
4 min read
U.S. Retractable Needle Safety Syringes Market | Growing Prevalence of Blood-Borne Pathogens is driving the Demand for Safety Syringe Designs

Syringes are ubiquitous in hospitals, clinics, nursing homes, dental laboratories, diagnostic centers, and homecare settings.

July 16, 2021
·
3 min read
Smart Syringe Pumps Market is driven by paradigm shift of economy from Conventional methods to Smart technologies – TMR’s Study

Smart syringe pump is a new technology that assists in the infusion of fluids with added reliability, can be used for controlled pressure, and flow.

July 16, 2021
·
3 min read
Deals

Core One Labs Announces Details of Consolidation to Meet Nasdaq Listing Requirements

Core One Labs Inc. is pleased to announce that it is pursuing a listing on the Capital Market tier of The Nasdaq Stock Market LLC (“ Nasdaq ”) to enhance the Company’s investor profile and increase value for its shareholders.

July 16, 2021
·
5 min read
Drug Development

Bristol Myers Squibb Provides Update on CheckMate -651 Trial Evaluating Opdivo (nivolumab) Plus Yervoy (ipilimumab) Versus EXTREME Regimen as First-Line Treatment for Squamous Cell Carcinoma of the Head and Neck

Bristol Myers Squibb announced an update on the Phase 3 CheckMate -651 trial comparing Opdivo plus Yervoy to the EXTREME regimen as a first-line treatment in platinum-eligible patients with recurrent or metastatic squamous cell carcinoma of the head and neck.

July 16, 2021
·
42 min read
Business

Biotage AB (publ) Interim report January - June 2021

Record quarterly net sales April–June Net sales amounted to SEK 303.5 (254.2) million, an increase of 19.4 percent and an organic* growth of 32.1 percent. The operating profit amounted to SEK 62.5 (24.5) million.

July 16, 2021
·
8 min read
Business

Trinity Biotech Provides A Business Development Update For Q2 2021

Trinity Biotech plc (Nasdaq: TRIB) provides a business development update for Q2 2021.

July 16, 2021
·
5 min read
Biotech Beach

eFFECTOR Therapeutics Announces Publication of Tomivosertib Preclinical Data in Cell ReportsPreclinical Data Demonstrate Role of eIF4E in Regulating Tumor Growth

eFFECTOR Therapeutics, Inc. announced today the publication of data highlighting the role of eukaryotic translation initiation factor 4E (“eIF4E”), in the peer-reviewed journal Cell Reports.

July 16, 2021
·
9 min read